190 related articles for article (PubMed ID: 16291713)
1. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
Finn A; Collins J; Voyksner R; Lindley C
J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prochlorperazine buccal tablets (Bukatel) and metoclopramide oral tablets in the treatment of acute emesis.
Singh S; Sharma DR; Chaudhary A
J Indian Med Assoc; 1999 Aug; 97(8):346-7. PubMed ID: 10643185
[TBL] [Abstract][Full Text] [Related]
3. Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting.
Bond CM
Curr Med Res Opin; 1998; 14(4):203-12. PubMed ID: 9891192
[TBL] [Abstract][Full Text] [Related]
4. Studies of prochlorperazine as a buccal tablet (Buccastem) and an oral tablet (Stemetil) for the treatment of dizziness, nausea or vomiting in a general practice setting.
Ward AE
Br J Clin Pract; 1988 Jun; 42(6):228-32. PubMed ID: 3061429
[No Abstract] [Full Text] [Related]
5. Clinical pharmacology of prochlorperazine in healthy young males.
Isah AO; Rawlins MD; Bateman DN
Br J Clin Pharmacol; 1991 Dec; 32(6):677-84. PubMed ID: 1768559
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.
Avram MJ; Spyker DA; Henthorn TK; Cassella JV
Clin Pharmacol Ther; 2009 Jan; 85(1):71-7. PubMed ID: 18830225
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film.
Nishimura M; Matsuura K; Tsukioka T; Yamashita H; Inagaki N; Sugiyama T; Itoh Y
Int J Pharm; 2009 Feb; 368(1-2):98-102. PubMed ID: 18992311
[TBL] [Abstract][Full Text] [Related]
9. Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs.
Avram MJ; Henthorn TK; Spyker DA; Krejcie TC; Lloyd PM; Cassella JV; Rabinowitz JD
Drug Metab Dispos; 2007 Feb; 35(2):262-7. PubMed ID: 17079359
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
11. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.
Dilger K; Halter J; Bertz H; Lopez-Lazaro L; Gratwohl A; Finke J
Biol Blood Marrow Transplant; 2009 Mar; 15(3):336-43. PubMed ID: 19203724
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy.
Morgan RJ; Synold T; Carr BI; Doroshow JH; Womack EP; Shibata S; Somlo G; Raschko J; Leong L; McNamara M; Chow W; Tetef M; Margolin K; Akman S; Longmate J
Cancer Chemother Pharmacol; 2001 Apr; 47(4):327-32. PubMed ID: 11345649
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic image (17). Acute dystonia induced by prochlorperazine].
van Gijn J
Ned Tijdschr Geneeskd; 2000 Dec; 144(52):2496. PubMed ID: 11155505
[TBL] [Abstract][Full Text] [Related]
15. Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance.
Ahmed S; El-Setouhy DA; El-Latif Badawi AA; El-Nabarawi MA
Eur J Pharm Sci; 2014 Aug; 60():10-23. PubMed ID: 24793896
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
Benchaoui HA; Cox SR; Schneider RP; Boucher JF; Clemence RG
J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metoclopramide, prochlorperazine and placebo in prevention of postoperative nausea and vomiting (PONV) following tonsillectomy in young adults.
Jamil M; Gilani SM; Khan SA
J Ayub Med Coll Abbottabad; 2005; 17(4):40-4. PubMed ID: 16599033
[TBL] [Abstract][Full Text] [Related]
19. Use of the buccal route for the administration of an antiemetic.
Patterson KW; Keane PW
Anesth Analg; 1992 Jun; 74(6):937-8. PubMed ID: 1595936
[No Abstract] [Full Text] [Related]
20. Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache.
Hoy SM; Scott LJ
CNS Drugs; 2011 Apr; 25(4):343-58. PubMed ID: 21425885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
